Neulasta Growth Factor Support

Find all needed information about Neulasta Growth Factor Support. Below you can see links where you can find everything you want to know about Neulasta Growth Factor Support.


Myeloid Growth Factor Support for Dose-Dense Adjuvant ...

    https://www.cancernetwork.com/oncology-journal/myeloid-growth-factor-support-dose-dense-adjuvant-chemotherapy-breast-cancer
    Dec 01, 2006 · Growth factor support is an essential component of therapy for several of the most commonly used adjuvant chemotherapy regimens that frequently cause substantial myelosuppression and anemia. Extensive data now exist to demonstrate the efficacy of both long- and short-acting myeloid growth factors in patients receiving dose-dense AC → paclitaxel.Cited by: 1

Neulasta - Chemotherapy Drugs - Chemocare

    http://chemocare.com/chemotherapy/drug-info/Neulasta.aspx
    Drug type: Neulasta is a biologic response modifier. It is classified as a colony stimulating factor. (For more detail, see "How this drug works" section below). What This Drug Is Used For: This medicine is used to stimulate the growth of "healthy" white blood cells in …

Growth Factors for Myelodysplastic Syndromes

    https://www.cancer.org/cancer/myelodysplastic-syndrome/treating/growth-factors.html
    Red blood cell growth factors. Epoetin (Epogen or Procrit) is a manmade version of the growth factor erythropoietin, which promotes red blood cell production. It can help some patients avoid red blood cell transfusions. Giving some patients both epoetin and G-CSF (see "White blood cell growth factors") can improve their response to the epoetin.

Myeloid growth factor support for dose-dense adjuvant ...

    https://www.ncbi.nlm.nih.gov/pubmed/17370924
    Growth factor support is an essential component of therapy for several of the most commonly used adjuvant chemotherapy regimens that frequently cause substantial myelosuppression and anemia. Extensive data now exist to demonstrate the efficacy of both long- and short-acting myeloid growth factors in patients receiving dose-dense AC --> paclitaxel.Cited by: 1

Algorithm for White Cell Growth Factor (G-CSF) Support

    http://www.lhsc.on.ca/Health_Professionals/LRCP/Oncology_Practice_Guidelines/LRCPGCSFalgorithmneutropeniaNov07.pdf
    Algorithm for White Cell Growth Factor (G-CSF) Support Step 1. Evaluate patient for risk of febrile neutropenia (FN) ... (Neulasta) 6mg once/cycle SC3,4 ... dose dense regimens require growth factor support for chemotherapy administration 1,4,5

Use of hematopoietic growth factors after chemotherapy ...

    https://www.ncbi.nlm.nih.gov/books/NBK12920/
    The use of hematopoietic growth factors as supportive care after chemotherapy revolves around several issues. These include the degree to which they are actually needed with standard-dose chemotherapy, whether or not high-dose chemotherapy with cytokine support is advantageous as compared with standard-dose chemotherapy, and the cost of the growth factors.188Author: Razelle Kurzrock



Need to find Neulasta Growth Factor Support information?

To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.

Related Support Info